Form 4 for TMO Thermo Fisher Scientific
Accepted 2025-11-10 00:00:00 ET · period of report 2025-11-07 · accession 0000097745-25-000161 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-11-10 | 2025-11-07 | TMO | Britt Lisa P. | SVP, Chief HR Off | S - Sale+OE | $571.62 | -10.2K | 14.1K | -42% | -$5.84M |
| D | 2025-11-10 | 2025-11-07 | TMO | Britt Lisa P. | SVP, Chief HR Off | M - OptEx | $253.99 | +8,475 | 22.6K | +60% | +$2.15M |
| D | 2025-11-10 | 2025-11-07 | TMO | Britt Lisa P. | SVP, Chief HR Off | M - OptEx | $0.00 | -8,475 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-07 | S | D | 8,475 | $571.67 | 14,144.80 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-07 | S | D | 1,750 | $571.40 | 14,144.80 | D | — | — | |
| 3 | Common | Common Stock | 2025-11-07 | M | A | 8,475 | $253.99 | 22,619.80 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-11-07 | M | D | 8,475 | $0.00 | 0 | D | $253.99 · — to 2026-02-26 | 8,475 Common Stock | (F1) The option vested in four equal installments on February 26, 2020, 2021, 2022, and 2023. |